Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiner, H. L.
Right arrow Articles by Dawson, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiner, H. L.
Right arrow Articles by Dawson, D. M.
NEUROLOGY 1980;30:1029
© 1980 American Academy of Neurology

Plasmapheresis in multiple sclerosis

Preliminary study

Howard L. Weiner, M. D. and David M. Dawson, M. D.

Neurology Section, Department of Medicine, Peter Bent Brigham Hospital, Boston, MA.

In six of eight patients with chronic progressive multiple sclerosis (MS) who were previously unresponsive to corticosteroid medication, moderate but unequivocal improvement occurred after short-term plasmapheresis, prednisone, and azathioprine therapy. In four patients, improvement gradually disappeared in the 2 to 3 months after therapy, and two patients have remained improved. There were no exacerbations during the treatment period. No consistent improvement in evoked response batteries was seen after plasmapheresis; IgG levels in cerebrospinal fluid were lowered by plasmapheresis. A controlled trial to determine the efficacy of plasmapheresis in the treatment of MS is warranted.

Address correspondence and reprint requests to Dr. Weiner, Neurology Section, Department of Medicine, Peter Bent Brigham Hospital, 721 Huntington Avenue, Boston, MA 02115.

Accepted for publication February 21, 1980.

Dr. Weiner is the recipient of a Teacher-Investigator Award from the National Institute of Neurological and Communicative Disorders and Stroke, No. NSI-EA1K07 NS 237–1 NSPB. The work was supported in part by the Kroc Foundation.




This article has been cited by other articles:


Home page
Mult SclerHome page
G. Comi, L. Leocani, S. Medaglini, T. Locatelli, V. Martinelli, G. Santuccio, and P. Rossi
Measuring evoked responses in multiple sclerosis
Multiple Sclerosis, August 1, 1999; 5(4): 263 - 267.
[Abstract] [PDF]


Home page
Mult SclerHome page
G Comi, V Martinelli, T Locatelli, L Leocani, and S Medaglini
Neurophysiological and cognitive markers of disease evolution in multiple sclerosis
Multiple Sclerosis, June 1, 1998; 4(3): 260 - 265.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. L. Rodnitzky and J. A. Goeken
Complications of Plasma Exchange in Neurological Patients
Arch Neurol, June 1, 1982; 39(6): 350 - 354.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.